Veno-arterial extracorporeal membrane oxygenation without allogeneic blood transfusion: An observational cohort study.
Alison GrazioliMichael E PlazakSiamak DahiJoseph RabinAshley MenneMehrdad GhoreishiBradley TaylorSeth PerelmanMichael A MazzeffiPublished in: Perfusion (2022)
Select patients can be successfully managed on V-A ECMO without allogeneic blood transfusion. Jehovah's Witnesses and other patients with objections to allogeneic transfusion might be offered V-A ECMO if its anticipated duration is short (e.g. <7 days) and baseline hemoglobin concentration is high (e.g. ≥10 mg/dL).
Keyphrases
- extracorporeal membrane oxygenation
- stem cell transplantation
- acute respiratory distress syndrome
- bone marrow
- respiratory failure
- end stage renal disease
- hematopoietic stem cell
- ejection fraction
- high dose
- newly diagnosed
- chronic kidney disease
- mechanical ventilation
- prognostic factors
- low dose
- acute kidney injury
- intensive care unit
- patient reported